AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |
| Novo Holdings A/S | 2,095,900 | $25,486,144 | 1.88% |
| Boxer Capital, LLC | 2,325,000 | $28,272,000 | 1.50% |
| AlphaCentric Advisors LLC | 132,500 | $1,611,200 | 0.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,078,865 | $13,118,998 | 0.83% |
| Ghost Tree Capital, LLC | 175,000 | $2,128,000 | 0.70% |
| Faithward Advisors, LLC | 272,173 | $2,795,217 | 0.68% |
| SevenOneSeven Capital Management | 23,989 | $246,368 | 0.57% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 10,376,763 | $126,181,438 | 0.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 90,000 | $1,092,600 | 0.37% |
| Rock Springs Capital Management LP | 1,063,806 | $12,935,881 | 0.35% |
External links
This page lists AMICUS THERAPEUTICS INC's shareholders in Q3 2023. To view AMICUS THERAPEUTICS INC's shareholder history, click here.